In–Vitro Susceptibility of Mycobacterium Tuberculosis to Amoxicillin–Clavulanate

Authors

Mojtaba Varshochi1,*, Mohammad Hossein Rastgar1, Abdolnaser Raffi1, Behrooz Nagil1
1Infectious Diseases and Tropical Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
*Corresponding Author: Infectious Diseases and Tropical Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Email: [email protected]

Archives of Clinical Infectious Diseases:Vol. 1, issue 3; e93388
Published online:Jul 30, 2006
Article type:Research Article
Received:May 12, 2019
Accepted:Jul 18, 2006
How to Cite:Varshochi M, Rastgar MH, Raffi A, Nagil B. In–Vitro Susceptibility of Mycobacterium Tuberculosis to Amoxicillin–Clavulanate. Arch Clin Infect Dis. 2006;1(3):e93388. doi:

Abstract

Background: The evidence of rapid spread of multidrug resistant Mycobacterium tuberculosis (MDR–TB) strains especially in high risk communities, persuade clinicians to find new drugs for this problem. β– lactams with few or no side effects has been reviewed as an alternative drugs for this issue. This study carried out to determine the effectiveness of amoxicillin–clavulanate in a group of Iranian patients.

Materials and methods: Amoxicillin–clavulanate was studied in five different minimal inhibitory concentrations (32- 512μg/ml) on 90 clinical strains of Mycobacterium tuberculosis (50 strains were sensitive and 40 were resistant to firstline anti-TB drugs).

Results: All strains were found resistant to amoxicillin–clavulanate in concentration of 32μg/ml. Only in concentration of 64μg/ml, sensitive strains (to first-line anti-TB drugs) were significantly more susceptible to amoxicillin–clavulanate than resistant strains. Five different MICs showed a non-significant difference in susceptibility to amoxicillin– clavulanate between strains with various resistance patterns to first-line anti-TB drugs. However, in 29 strains MIC were above 512μg/ml.

Conclusion: Although amoxicillin–clavulante might be a suitable candidate as a second-line anti-TB drug, further clinical trials are required to draw a firm conclusion.

References

  • 1.
    The references are available in PDF file.

Copyright

© 2006, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

13
Jul
2025
Evaluation of the Activity of Amoxicillin/Clavulanate, Ceftazidime/Avibactam and Colistin Against Drug-Resistant Mycobacterium tuberculosis Isolates by the E-test Method

Evaluation of the Activity of Amoxicillin/Clavulanate, Ceftazidime/Avibactam and Colistin Against Drug-Resistant Mycobacterium tuberculosis Isolates by the E-test Method

Cemilenur Atas,
Tuba Astarcioglu,
Kubra Yildirim,
Mehmet Akif Gun,
Emel Kaynakci,
Deniz Turgut Coban
,et al.

Atas C, Astarcioglu T, Yildirim K, Gun MA, Kaynakci E, et al. Evaluation of the Activity of Amoxicillin/Clavulanate, Ceftazidime/Avibactam and Colistin Against Drug-Resistant Mycobacterium tuberculosis Isolates by the E-test Method. Jundishapur J Microbiol. 2025;18(7):e162034. doi: https://doi.org/10.5812/jjm-162034

6
Dec
2014

Oral Amoxicillin-Clavulanic Acid Treatment in Urinary Tract Infections Caused by Extended-Spectrum Beta-Lactamase–Producing Organisms

Ali Beytur,
Yusuf Yakupogullari,
Fatih Oguz,
Baris Otlu,
Halim Kaysadu

Beytur A, Yakupogullari Y, Oguz F, Otlu B, Kaysadu H. Oral Amoxicillin-Clavulanic Acid Treatment in Urinary Tract Infections Caused by Extended-Spectrum Beta-Lactamase–Producing Organisms. Jundishapur J Microbiol. 2015;8(1):e59735. doi: https://doi.org/10.5812/jjm.13792

13
Nov
2019
Prevalence of Multidrug-Resistant Tuberculosis: A Six-Year Single-Center Retrospective Study in Tehran, Iran

Prevalence of Multidrug-Resistant Tuberculosis: A Six-Year Single-Center Retrospective Study in Tehran, Iran

Shadi Habibnia,
Saeed Zaker,
Mohammad Javad Nasiri,
Farahnoosh Doustdar,
Zohreh Ghalavand,
Mostafa Ghalami
,et al.

Habibnia S, Zaker S, Nasiri MJ, Doustdar F, Ghalavand Z, et al. Prevalence of Multidrug-Resistant Tuberculosis: A Six-Year Single-Center Retrospective Study in Tehran, Iran. Arch Clin Infect Dis. 2019;14(5):e82828. doi: https://doi.org/10.5812/archcid.82828

26
Jan
2015

Susceptibility Pattern of Bacille Calmette-Guerin Strains Against Pyrazinamide and Other Major Anti-Mycobacterial Drugs

Seyed Alireza Fahimzad,
Mahmood Ghasemi,
Farideh Shiva,
Keyghobad Ghadiri,
Masoumeh Navidinia,
Abdollah Karimi

Fahimzad SA, Ghasemi M, Shiva F, Ghadiri K, Navidinia M, et al. Susceptibility Pattern of Bacille Calmette-Guerin Strains Against Pyrazinamide and Other Major Anti-Mycobacterial Drugs. Arch Pediatr Infect Dis. 2015;3(1 TB):e17814. doi: https://doi.org/10.5812/pedinfect.17814

20
Apr
2021
Prevalence and Antimicrobial Susceptibility of Non-tuberculous Mycobacteria Isolated from Sputum Samples of Patients with Pulmonary Infections in China

Prevalence and Antimicrobial Susceptibility of Non-tuberculous Mycobacteria Isolated from Sputum Samples of Patients with Pulmonary Infections in China

Wenjun Zhou,
Hong Zhao,
Hongping Yuan,
Guiyun Zhang,
Qisha Liu,
Jie Yang

Zhou W, Zhao H, Yuan H, Zhang G, Liu Q, et al. Prevalence and Antimicrobial Susceptibility of Non-tuberculous Mycobacteria Isolated from Sputum Samples of Patients with Pulmonary Infections in China. Jundishapur J Microbiol. 2021;14(1):e109676. doi: https://doi.org/10.5812/jjm.109676

More by these authors

Mojtaba VarshochiPubMedScholar
Mohammad Hossein RastgarPubMedScholar
Abdolnaser RaffiPubMedScholar
Behrooz NagilPubMedScholar
Share
Cited by
Metrics